SARS-CoV-2 is the etiological agent responsible for the ongoing COVID-19 pandemic,
which continues to spread with devastating effects on global health and socioeconomics …

As new pathogens emerge, new challenges must be faced. This is no different in infectious
disease research, where identifying the best tools available in laboratories to conduct an …

SARS-CoV-2 and filovirus enter cells via the cell surface angiotensin-converting enzyme 2
(ACE2) or the late-endosome Niemann-Pick C1 (NPC1) as a receptor. Here, we screened …

Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused substantial morbidity and …

The SARS-CoV-2 spike protein is heavily glycosylated, having 22 predicted N-glycosylation
sites per monomer. It is also O-glycosylated, although the number of O-glycosites is less …

Exploring wild reservoirs of pathogenic viruses is critical for their long-term control and for
predicting future pandemic scenarios. Here, a comparative in vitro infection analysis was first …

The angiotensin‐converting enzyme 2 (ACE2) has been identified as entry receptor on cells
enabling binding and infection with the severe acute respiratory syndrome coronavirus 2 …

The unique mutations of the SARS-CoV-2 Omicron variant are associated with increased
transmissibility, immune escape, increased binding affinity to ACE-2, and increased viral …

We aimed to assess the performance of Ag‐RDT and RT‐qPCR with regard to detecting
infectious SARS‐CoV‐2 in cell cultures, as their diagnostic test accuracy (DTA) compared to …

The coronavirus SARS-CoV-2 has caused a pandemic with> 550 millions of cases and> 6
millions of deaths worldwide. Medical management of COVID-19 relies on supportive care …